Morphological characteristics of hypertrophic cardiomyopathy estimated by left ventriculography

T Ohtani1, M Hamada, K Hiwada

  • 1Second Department of Internal Medicine, Ehime University School of Medicine, Japan.

Insights

Hypertrophic cardiomyopathy (HCM) shows a characteristic leftward ventricular convexity due to interventricular septum hypertrophy. This morphological change significantly impacts cardiac performance, particularly stroke index.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Pathology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • Understanding its morphological variations is crucial for diagnosis and management.
  • Right anterior oblique ventriculography offers insights into left ventricular (LV) and interventricular septum (IVS) anatomy.

Purpose of the Study:

  • To identify common morphological features of HCM using right anterior oblique (RAO) ventriculography.
  • To compare these features between obstructive HCM (HOCM) and nonobstructive HCM (HNCM) patients.
  • To correlate morphological findings with cardiac performance metrics.

Main Methods:

  • Analysis of RAO ventriculograms in 15 HOCM, 32 HNCM patients, and 17 controls.
  • Evaluation of diaphragmatic and free wall configurations.
  • Measurement of IVS hypertrophy (M point), LV shape distortion, and LV free wall (LVFW) thickness.

Main Results:

  • All HCM patients exhibited IVS hypertrophy causing a convexity into the LV in RAO view.
  • The M point (maximal septal thickness) was basilar in HOCM and more apical in HNCM.
  • LV showed catenoid distortion at the M point, more severe in HOCM; LVFW thickness increased apically in 53% of HNCM patients.
  • Cardiac and stroke indices were reduced in HCM, correlating with M point position.

Conclusions:

  • A common RAO ventriculographic finding in HCM is a diaphragmatic convexity due to IVS hypertrophy.
  • The nature of this convexity significantly influences cardiac performance.
  • Myocardial abnormalities in HOCM appear basal in the IVS, while HNCM shows abnormalities in the lower IVS and LVFW.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...